IL6 and cancer: LIF is a highly pleiotropic member of the IL-6 family of cytokines, upon binding to the LIFR complex promotes the crosstalk between the extracellular matrix (ECM) and cancer cells and mediates the transition through a pro-invasive phenotype of stromal fibroblasts and cancer cells [32].